The Good Future team was invited to participate in the "2022 Cancer Innovative Precision Detection Implementation Workshop" academic exchange event jointly organized by Changhua Christian Hospital and the Metal Industry Research and Development Center on July 8, 2022.
This event invites Dr. Lai Guanming, director of the Department of Hematology and Oncology at Changji, to share his experience in innovative precision medicine for cancer in Changji. In addition, five Taiwanese precision medicine manufacturers including Good Future are invited to share and exchange cancer screening technologies. During the event, Good Future Dr. Hong Weishan gave a lecture on "circulating tumor cells Testing Past-Present-Future". The "Chiline CATCH" circulating tumor cells Testing Service (CTC) introduced in the speech aroused heated discussion among participating doctors and experts.
Good Future's CTC testing services include the following features and are undoubtedly the biggest focus in the venue.
1. Mature negative screening principle, concentrating and enriching cancer cells.
2. Start the fully automated program with one touch.
3. Process four samples simultaneously, and can produce eight samples in one day.
4.AI counting software automatically interprets CTC values.
Thanks to Gao Xiaoling, CEO of Changji International Medical Center, for inviting us to this event and for inviting us to Thailand this September to participate in the Taiwan-Thailand Smart Medical Seminar, so as to bring Taiwan’s precision medicine to the world!
